Digital Therapeutics (DTx)

At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

In this paper, Castor explores the benefits and challenges of Digital Therapeutics (DTx) trials and provides recommendations on best practices for data collection and management.

Tech tools help Digital Therapeutics (DTx) maximize the impact of the real-world data they capture, explore how in this blog from Castor

In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the path to market

The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these challenges

Digital Therapeutics (DTx) is a rapidly growing space whose players are facing challenges in scaling their businesses, including testing. Learn more about growing successfully.

Cybersecurity has become a concern for Digital Therapeutics (DTx) developers and regulatory bodies. Learn to balance functionality & security.

Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization.

A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and maintain public trust.